Rafa Laboratories Ltd. (TLV:RAFA)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,469.00
-4.00 (-0.27%)
At close: Aug 13, 2026
Rafa Laboratories Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 31.8 | 10.71 | 12.53 | - |
Short-Term Investments | 0.35 | 0.35 | 0.29 | - |
Cash & Short-Term Investments | 32.15 | 11.06 | 12.82 | - |
Cash Growth | - | -13.73% | - | - |
Accounts Receivable | 72.6 | 110.57 | 78.42 | - |
Other Receivables | 1.82 | 1.02 | 1.67 | - |
Receivables | 78.62 | 115.88 | 84.12 | - |
Inventory | 59.27 | 65.33 | 69.48 | - |
Other Current Assets | 9.73 | 4.93 | 1.09 | - |
Total Current Assets | 179.77 | 197.2 | 167.51 | - |
Property, Plant & Equipment | 113.19 | 109.96 | 116.16 | - |
Long-Term Investments | 8.54 | 8.42 | 8.82 | - |
Other Intangible Assets | 10.56 | 10.55 | 4.45 | - |
Long-Term Deferred Tax Assets | 0.67 | 0.53 | 0.47 | - |
Other Long-Term Assets | 8.19 | 8.01 | 5.84 | - |
Total Assets | 320.92 | 334.67 | 303.25 | - |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 34.72 | 54.64 | 38.03 | - |
Accrued Expenses | - | 12.59 | 11.56 | - |
Short-Term Debt | - | 12.05 | - | - |
Current Portion of Leases | 0.22 | 0.23 | 1.74 | - |
Current Unearned Revenue | - | - | 0.52 | - |
Other Current Liabilities | 18.32 | 10.22 | 7.1 | - |
Total Current Liabilities | 53.26 | 89.72 | 58.95 | - |
Long-Term Leases | 4.12 | 4.52 | 4.35 | - |
Pension & Post-Retirement Benefits | 0.53 | 0.53 | 0.49 | - |
Other Long-Term Liabilities | 8.63 | 8.89 | 7.93 | - |
Total Liabilities | 66.53 | 103.66 | 71.72 | - |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 35.39 | 35.39 | 35.39 | - |
Additional Paid-In Capital | 20.29 | 19.17 | 15.04 | - |
Retained Earnings | 198.71 | 176.45 | 181.11 | - |
Shareholders' Equity | 254.38 | 231.01 | 231.53 | - |
Total Liabilities & Equity | 320.92 | 334.67 | 303.25 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 4.34 | 16.8 | 6.08 | - |
Net Cash (Debt) | 27.81 | -5.74 | 6.73 | - |
Net Cash Growth | - | - | - | - |
Net Cash Per Share | 0.01 | -0.00 | 0.00 | - |
Filing Date Shares Outstanding | 2,855 | 284,647 | 2,924 | 2,879 |
Total Common Shares Outstanding | 2,855 | 284,647 | 2,924 | 2,879 |
Working Capital | 126.52 | 107.48 | 108.56 | - |
Book Value Per Share | 0.09 | 0.00 | 0.08 | - |
Tangible Book Value | 243.83 | 220.46 | 227.08 | - |
Tangible Book Value Per Share | 0.09 | 0.00 | 0.08 | - |
Buildings | - | 141.18 | 141.1 | - |
Machinery | - | 74.93 | 71.55 | - |